A PIONEERING SPIRIT
In addition to the R&D programs in each of its companies, Institut Mérieux has created a unique system to boost and accelerate scientific innovation.
• More than 12% of its sales invested in R&D
• 2 companies focused on innovation:
Mérieux Développement, an investment company that funds tomorrow’s health care,
and ABL Inc., a contract research organization
• An open innovation strategy based on operational collaborations
• the creation of joint laboratories with academic researchers and the international hospital community
• The Mérieux Research Grants program, whose objective is to fund academic teams that are developing conceptual or technological innovations and create a global network of experts working on the group’s thematic priorities
• Cross-disciplinary programs, addressing major public health challenges in a comprehensive and multidisciplinary way, by taking advantage of the complementary expertise of the group’s companies as well as international academic networks